Nova Eye Medical Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 17.03 million compared to AUD 13.38 million a year ago. Net loss was AUD 15.29 million compared to AUD 7.5 million a year ago.

Basic loss per share from continuing operations was AUD 0.0981 compared to AUD 0.0518 a year ago. Diluted loss per share from continuing operations was AUD 0.0981 compared to AUD 0.0518 a year ago.